[Federal Register: July 24, 2008 (Volume 73, Number 143)]
[Notices]               
[Page 43259-43260]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24jy08-95]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 13, 2008 and published in the Federal 
Register on February 21, 2008, (73 FR 9592), Johnson Matthey, Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066-1742, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Lisdexamfetamine (1205), a basic class of controlled substance listed 
in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Johnson Matthey, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection

[[Page 43260]]

and testing of the company's physical security systems, verification of 
the company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823, 
and in accordance with 21 CFR 1301.33, the above named company is 
granted registration as a bulk manufacturer of the basic class of 
controlled substance listed.

    Dated: July 15, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-16905 Filed 7-23-08; 8:45 am]

BILLING CODE 4410-09-P